无毒多结构域肉毒神经毒素-LCHCN作为抗肉毒中毒疫苗
肉毒神经毒素(BoNT)是肉毒中毒的致病因子,目前尚无获批的人用肉毒疫苗。腹腔免疫小鼠可诱导强IgG应答,分别抵御高剂量BoNT/A1或BoNT/B1攻击。4MBoNT/B1和7MBoNT/B1同样诱导强IgG应答并抵御高剂量BoNT/B1攻击。
要点
- 腹腔免疫6MLCHCN/A1或6MLCHCN/B1诱导强IgG应答,分别抵御高剂量BoNT/A1或BoNT/B1攻击。
- 4MBoNT/B1和7MBoNT/B1也诱导强IgG应答,抵御高剂量BoNT/B1攻击。
核心结论
- 多结构域失活策略可能产生针对其他BoNT血清型和BoNT样蛋白的有效且安全的疫苗。
- 通过靶向单氨基酸替换系统失活多个功能结构域以降低毒性,并结合对最具免疫原性和保护性结构域的研究,为人和动物蛋白毒素疫苗提供了稳健平台。
研究设计与样本
- 本研究为实验性疫苗研究,构建了在LCHCN/A1和LCHCN/B1的底物结合与切割位点、锌结合基序及LC转位区引入六个单点替换(6M)的突变体,以及4MBoNT/B1和7MBoNT/B1。
- 在小鼠中评估毒性(200 μg剂量)并通过腹腔免疫评估IgG应答和保护效果。
主要发现
- 腹腔免疫6MLCHCN/A1或6MLCHCN/B1的小鼠产生强IgG应答,分别抵御高剂量BoNT/A1或BoNT/B1攻击。
- 4MBoNT/B1和7MBoNT/B1诱导强IgG应答,抵御高剂量BoNT/B1攻击。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Botulinum neurotoxins (BoNTs), the causative agents of botulism, are proteins consisting of an N-terminal catalytic Light Chain (LC) and a C-terminal Heavy Chain (HC), which comprises a LC-translocation domain (HCN) and a receptor binding domain (HCC). There are seven BoNT serotypes (A-G) and multiple subtypes. Currently, there is no approved vaccine against botulism available for human use. Several studies have investigated BoNT domains, multi-domains, or mutated holotoxins as candidate BoNT vaccines. However, residual toxicity has been observed in mutated full-length BoNTs and multi-domain (LCHCN) vaccines. In this study, six-individual point substitutions (6M) were introduced into the substrate binding and cleavage sites, zinc binding motif, and LC translocation region of LCHCN/A1 and LCHCN/B1, which possessed no detectable toxicity in mice at 200 μg, being >40-million-fold less toxic than full-length BoNT. IP immunization of mice with 6MLCHCN/A1 or 6MLCHCN/B1 elicited a strong IgG response that protected against high dose challenge with BoNT/A1 or BoNT/B1, respectively. 4MBoNT/B1 and 7MBoNT/B1 were also engineered and found to elicit strong IgG responses that protected against high dose challenge with BoNT/B1. Thus, multi-domain inactivation may yield potent and safe vaccines against other BoNT-serotypes and BoNT-like proteins. The strategy of systematic inactivation of multiple functional domains by targeted single amino acid substitutions to decrease toxicity, combined with investigations of the most immunogenic and protective domains, provides a robust platform for protein toxin vaccines for humans and animals.
引用
- Przedpelski A, Tepp WH, Gupta S, et al. Nontoxic, multi-domain botulinum neurotoxin-LCHCN as vaccines against botulism. Vaccine. 2025. PMID: 40997375. doi:10.1016/j.vaccine.2025.127779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。